Biliary Tract Cancer Clinical Trials in Pittsburgh, Pennsylvania
7 recruitingPittsburgh, Pennsylvania
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Biliary Tract Cancer
AstraZeneca1,100 enrolled168 locationsNCT07221253
Recruiting
Phase 3
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Biliary Tract Cancer (BTC)Advanced Biliary Tract Cancer
J-Pharma Co., Ltd.480 enrolled18 locationsNCT07265674
Recruiting
Phase 2
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Biliary Tract CancerHepatocellular Carcinoma
Replimune Inc.60 enrolled11 locationsNCT05733598
Recruiting
Phase 1
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Breast CancerBiliary Tract CancerOvarian Cancer+3 more
NextCure, Inc.145 enrolled14 locationsNCT06774963
Recruiting
Phase 1Phase 2
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Pancreatic Ductal AdenocarcinomaBiliary Tract Cancer (BTC)Gastric or Gastroesophageal Junction Adenocarcinoma
Phanes Therapeutics258 enrolled11 locationsNCT05482893
Recruiting
Not Applicable
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
Gynecologic CancersColorectal, CancerBiliary Tract Cancer+8 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)48 enrolled1 locationNCT06731998
Recruiting
Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
Biliary Tract CancerCholangiocarcinomaBiliary Tract Neoplasms
Udai Kammula59 enrolled1 locationNCT03801083